Health economics and clinical pathology.

Por Harnden, P
Publicado em 1998

Cytokeratin 14 as a marker of squamous differentiation in transitional cell carcinomas.

Por Harnden, P, Southgate, J
Publicado em 1997

ACP Broadsheet No 146: August 1995. Macroscopic examination of prostatic specimens.

Por Harnden, P, Parkinson, M C
Publicado em 1995

Which proliferation markers for routine immunohistology?

Por Southgate, J, Harnden, P, Holt, J
Publicado em 1996

FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer

Por Tomlinson, DC, Baldo, O, Harnden, P, Knowles, MA
Publicado em 2007

Postmenopausal cystitis. Bladder cancer may be a cause, but interstitial cystitis is an unusual differential diagnosis.

Por Turner, W., Eardley, I., Joyce, A. D., Harnden, P.
Publicado em 1996

Expression of NRG1 and its receptors in human bladder cancer

Por Forster, J A, Paul, A B, Harnden, P, Knowles, M A
Publicado em 2011

Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein

Por Jagdev, S P K, Gregory, W, Vasudev, N S, Harnden, P, Sim, S, Thompson, D, Cartledge, J, Selby, P J, Banks, R E
Publicado em 2010

Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer

Por Protheroe, A S, Banks, R E, Mzimba, M, Porter, W H, Southgate, J, Singh, P N, Bosomworth, M, Harnden, P, Smith, P H, Whelan, P, Selby, P J
Publicado em 1999